FDA
-
-
-
-
-
-
-
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
-
-
-
-
-
-
-
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
-
-
-
-
-
-
-
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
-
-
-
-
-
-
-
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
-
-
-
-
-
-
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
-
-
-
-
-
-
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
-
322,948 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

